Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genus Oncology LLC
DescriptionPeptide that blocks the ability of MUC1 to oligomerize
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today